JTCS Speed Up Your Browser
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dajee, H.
Right arrow Articles by Szarnicki, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dajee, H.
Right arrow Articles by Szarnicki, R. J.

The Journal of Thoracic and Cardiovascular Surgery, Vol 85, 718-726, Copyright © 1983 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Cardiac valve replacement in systemic lupus erythematosus. A review

H Dajee, EJ Hurley and RJ Szarnicki

Three cases of cardiac valve replacement for Libman-Sacks endocarditis and their long-term follow-up are described. From the review of the literature, an additional nine patients who required cardiac valve replacement are studied. Steroids probably increase the incidence of valve incompetence, but most patients presumably die of other associated organ involvement before undergoing a cardiac operation. Operation is indicated because of change in the intensity or character of the murmur, and a new murmur with resultant, resistant congestive cardiac failure. Both the aortic and mitral valves should be explored. Valve reconstruction in these young patients, with the expectation of avoiding prosthetic valve dysfunction and repeat operation, is not possible. Bioprosthetic valve replacement may be preferable, since it eliminates the need for anticoagulation during steroid treatment. Overall mortality was 25%.


This article has been cited by other articles:


Home page
 Br J AnaesthHome page
R. I. P. Dornan
Acute postoperative biventricular failure associated with antiphospholipid antibody syndrome
Br. J. Anaesth., May 1, 2004; 92(5): 748 - 754.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
Y. Berkun, A. Elami, K. Meir, D. Mevorach, and Y. Naparstek
Increased morbidity and mortality in patients with antiphospholipid syndrome undergoing valve replacement surgery
J. Thorac. Cardiovasc. Surg., February 1, 2004; 127(2): 414 - 420.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
S Bujan, J Ordi-Ros, J Paredes, M Mauri, L Matas, J Cortes, and M Vilardell
Contribution of the initial features of systemic lupus erythematosus to the clinical evolution and survival of a cohort of Mediterranean patients
Ann Rheum Dis, September 1, 2003; 62(9): 859 - 865.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
C. A. Roldan, B. K. Shively, and M. H. Crawford
An Echocardiographic Study of Valvular Heart Disease Associated with Systemic Lupus Erythematosus
N. Engl. J. Med., November 7, 1996; 335(19): 1424 - 1430.
[Abstract] [Full Text] [PDF]

Home page
 LupusHome page
S. Morelli, C. Perrone, and G. Valesini
Tricuspid Valve Steno-Insufficiency in Systemic Lupus Erythematosus
Lupus, August 1, 1995; 4(4): 318 - 320.
[Abstract] [PDF]

Home page
 NEJMHome page
S.A. Abraham and K.K. Hansen
Case 11-1995- A 39-year-old man with chronic renal failure, aortic regurgitation, and a calcified mass about the aortic root
N. Engl. J. Med., April 13, 1995; 332(15): 1015 - 1022.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1983 by The American Association for Thoracic Surgery.